Extract
Covidien Launches EXALGO[TM] Extended-Release Tablets.
New extended-release formulation available for around-the-clock pain management
ST. LOUIS -- Covidien (NYSE: COV), a leading global provider of healthcare products, today introduced EXALGO[TM] (hydromorphone HCI) Extended-Release Tablets, (CII), the only extended-release hydromorphone treatment available in the United States. This proven therapy, combined with an innovative...See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
Jonesboro considers adding public transit. | robert s forman and matthew a linde have become associated with henderson franklin starnes & holt p.a. | Tonko Announces First Quarter Financial Results. | Tax-Free Archer Medical Savings Accounts Offer Biggest Benefit For Early Savers Says Flexible Benefit Service Corporation. | Decisión nº S-N de Juzgado Primero Ejecutor de Medidas de los Municipios Maracaibo, Jesús Enrique Lossada, San Francisco, Mara, Almirante Padilla y Páez de Zulia, d... | Decisión de Juzgado del Municipio Lagunillas de Zulia de September 16 2005 | Sentencia nº 5432 de Consiglio di Stato, October 28, 2009 | Sentencia nº 1105 de Consiglio di Stato March 03 2009
